In summary, the outcome showed that miR-27b-3p could repress BC cell proliferation and invasion by aiming at EN2; however, the up-regulation of EN2 could reverse the inhibitory effects of miR-27b-3p on BC cells. Here, EN2 is linked to breast cancer.